Directory of Drugs: Gefitinib - Iressa
FDA ALERT [06/2005]: FDA has approved new labeling for Iressa that states the medicine should be used only in cancer patients who have already taken the medicine and whose doctor believes it is helping them. New patients should not be given Iressa because in a large study Iressa did not make people live longer. There are other medicines for non-small cell lung cancer (NSCLC) that have shown an ability to make people live longer.
What Is Iressa?
Iressa is a medicine used to kill cancer cells (chemotherapy). It is used alone for the continued treatment of patients who are benefiting or have benefited from Iressa. Iressa is approved for patients with non-small cell lung cancer (NSCLC) that:
What Are The Risks?
The following are the major possible risks and side effects of Iressa therapy. This list is not complete.
What Should I Tell My Healthcare Professional?
Before being treated with Iressa tell your healthcare professional if you:
While being treated with Iressa call your healthcare professional right away if you develop:
Are There Any Interactions With Drugs or Foods?
Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter drugs, and supplements. Especially tell your health care provider if you take:
© 2007 Directory of Drugs - reference guide to drugs - All rights reserved - Legal Notice